Last reviewed · How we verify
NCT06362551
Oocyte Donor Application Discrepancies
trial in Infertility in 600 participants. Completed in 24 April 2024.
24 April 2024
Quick facts
| Lead sponsor | Inception Fertility Research Institute, LLC |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 600 |
| Start date | 25 March 2024 |
| Primary completion | 24 April 2024 |
| Estimated completion | 24 April 2024 |
| Sites | 1 location across United States |
Conditions studied
- Infertility — all drugs for Infertility →
Sponsor
Inception Fertility Research Institute, LLC — full company profile →
Who can join
Eligibility, female only, with Infertility. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Retrospective observational study comparing information received on Inception Central Donor Recruitment's standardized online egg donor application compared to information reported during a Genetic Risk Assessment (GRA) consultation with a certified genetic counselor with contracted third party genetic counseling service, GeneScreen. All donor applicants completing a full application with Inception's Central Donor Recruitment and a GRA consultation with GeneScreen will be included.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06362551
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Infertility
Currently open trials in the same condition.
- NCT07074015 — IntelliWell: An AI-Assisted Imaging Platform for Detection and Location of Ultra-Rare Testicular Sperm in Surgical Speci · NA · recruiting
- NCT07358468 — Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study · recruiting
- NCT07340827 — A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH · Phase 3 · recruiting
- NCT07369362 — To Investigate if the Harvester® Improves Sperm Motility and Blastocyst Utilization (the Percent of Fertilized Eggs That · NA · active not recruiting
- NCT07153367 — Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauter · Phase 2 · recruiting
Other Inception Fertility Research Institute, LLC trials
Trials by the same sponsor.
- NCT07134920 — Norethindrone Impact on Receptiva Outcomes · completed
- NCT06454058 — Association Between Euploid Embryo Grade and Maternal Age · terminated
- NCT06373237 — Outcome of Embryos Transferred After Initial Chaotic Results on PGT-A · completed
- NCT06068634 — Patient-Centered Care Survey · completed
- NCT05589571 — Evaluation of the Impact of Stress on IVF Outcome · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06362551 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Inception Fertility Research Institute, LLC
- Last refreshed: 16 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06362551.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing